Ahmed Olowo-Okere1, Abdourahamane Yacouba2. 1. PharmD, PhD, Usmanu Danfodiyo University, Faculty of Pharmaceutical Sciences, P.M.B. 2346, Sokoto, Nigeria. 2. MD, Université Abdou Moumouni, Faculté des Sciences de la Santé, P.M.B. 10896, Niamey, Niger.
Abstract
INTRODUCTION: Updated and comprehensive data on the mechanism underlying colistin resistance is lacking in Africa. LITERATURE SEARCH: Herein, we aimed to review available literature on the molecular mechanisms of colistin resistance in Africa. PubMed, Google Scholar, and African Journal online databases were searched on the 15th of January 2020 for original research articles that reported mechanisms of colistin resistance in any of the 54 African countries. REVIEW: Of the 1473 studies identified through initial database search, 36 met the inclusion criteria. Colistin resistance was mostly observed in Escherichia coli isolated from human clinical samples. Plasmid-mediated colistin resistance mechanism (26; 72.2%) was the most frequently reported resistance mechanism. About three-quarters (27; 75.0%) of the 36 studies were done in North Africa. In this zone, the mobilized colistin resistance (mcr) genes were mostly detected in E. coli harboring three plasmid types, IncHI2, IncI2, and IncX4, from animal samples (n=9; 42.8%). Of the six studies performed in Southern Africa, four reported mcr-1 mostly detected from human samples (n=2; 50.0%) in E. coli isolates carrying IncHI2, IncI2, and IncX4 with diverse range of STs. One hitherto unknown mutation, the mutation in the I527N gene was detected in colistin resistant isolates in this region, which was absent in colistin susceptible isolates. In West and Central Africa, two and one studies, respectively, reported mcr-1 gene exclusively in Escherichia coli isolates. CONCLUSIONS: Transferable plasmid mediated colistin resistance is rapidly emerging in Africa with mcr-1 as the predominant genetic variant in human, animals, and environmental samples. GERMS.
INTRODUCTION: Updated and comprehensive data on the mechanism underlying colistin resistance is lacking in Africa. LITERATURE SEARCH: Herein, we aimed to review available literature on the molecular mechanisms of colistin resistance in Africa. PubMed, Google Scholar, and African Journal online databases were searched on the 15th of January 2020 for original research articles that reported mechanisms of colistin resistance in any of the 54 African countries. REVIEW: Of the 1473 studies identified through initial database search, 36 met the inclusion criteria. Colistin resistance was mostly observed in Escherichia coli isolated from human clinical samples. Plasmid-mediated colistin resistance mechanism (26; 72.2%) was the most frequently reported resistance mechanism. About three-quarters (27; 75.0%) of the 36 studies were done in North Africa. In this zone, the mobilized colistin resistance (mcr) genes were mostly detected in E. coli harboring three plasmid types, IncHI2, IncI2, and IncX4, from animal samples (n=9; 42.8%). Of the six studies performed in Southern Africa, four reported mcr-1 mostly detected from human samples (n=2; 50.0%) in E. coli isolates carrying IncHI2, IncI2, and IncX4 with diverse range of STs. One hitherto unknown mutation, the mutation in the I527N gene was detected in colistin resistant isolates in this region, which was absent in colistin susceptible isolates. In West and Central Africa, two and one studies, respectively, reported mcr-1 gene exclusively in Escherichia coli isolates. CONCLUSIONS: Transferable plasmid mediated colistin resistance is rapidly emerging in Africa with mcr-1 as the predominant genetic variant in human, animals, and environmental samples. GERMS.
Authors: Meriem Touati; Linda Hadjadj; Meryem Berrazeg; Sophie Alexandra Baron; Jean Marc Rolain Journal: J Glob Antimicrob Resist Date: 2019-10-10 Impact factor: 4.035
Authors: Mai M Zafer; Hadir A El-Mahallawy; Asmaa Abdulhak; Magdy A Amin; Mohamed H Al-Agamy; Hesham H Radwan Journal: Ann Clin Microbiol Antimicrob Date: 2019-12-12 Impact factor: 3.944